GSS EU Science Funding Gateway

The proposed research is expected to deliver on the following:

• Carry out phase IV/implementation research studies on the deployment and uptake of registered vaccines in SSA, examining operational aspects, access, coverage, vaccine acceptability/hesitancy, community engagement, real-life impact on overall health and cost-effectiveness;
• Develop and test novel logistical solutions for vaccination;
• As relevant, develop and test novel clinical solutions for vaccine delivery, including new delivery modes;
• Gain a better understanding of different health care systems in sub-Saharan Africa as regards the factors driving structural inequalities in vaccine deliveries;
• Identify the social, economic, political, religious, cultural, and personal factors driving vaccine hesitancy in SSA and develop targeted solutions, as appropriate. Vaccine hesitancy should be considered in the context of the specificities of different types of vaccines and their perceived risks and benefits. It is further essential to investigate the factors that are undermining coverage in different countries, regions, or communities both in terms of vaccine types and doses received. In many cases, this means targeted collaborations with local leaders who can effectively address their communities’ concerns and with caregivers who bring children to vaccination services. Applicants are also encouraged to develop evidence-based tools that can guide people towards informed vaccination decisions, delivering tailored information based on each user’s concerns.

Applicants need to concisely describe any prior research findings and explain how the proposal builds on these results. Building on relevant results from projects supported under previous EDCTP programmes is encouraged.

The implementation research to be conducted must involve vulnerable groups, including participants from poorer, underserved, or hard-to-reach communities in SSA. Applicants are also encouraged to provide methodologies for translating research findings into public health practice and policy guidelines. They are welcome to draw on any relevant lessons from the COVID-19 vaccination strategies.

International cooperation is encouraged, and the proposed research is expected to be multidisciplinary through the involvement of medical sciences, psychological sciences, social sciences, and the humanities.